Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Costco stock slips in year-end session as traders eye Jan. 7 sales update for COST

Costco stock slips in year-end session as traders eye Jan. 7 sales update for COST

NEW YORK, December 31, 2025, 14:14 ET — Regular session Costco Wholesale Corporation shares were slightly lower on Wednesday as Wall Street eased in the final trading session of 2025. The muted move matters because Costco is closely watched as a bellwether for value-focused spending and membership-driven retail, especially heading into fresh monthly sales data in early January. It also comes during thin holiday trading, when smaller orders can have an outsized impact on prices and investors reposition ahead of the New Year’s market break. Costco shares were down $1.28, or about 0.1%, at $864.37 in afternoon trading. The stock
Exxon Mobil stock slips today as oil heads for biggest annual drop since 2020

Exxon Mobil stock slips today as oil heads for biggest annual drop since 2020

NEW YORK, December 31, 2025, 14:11 ET — Regular session. Exxon Mobil (XOM) shares edged lower on Wednesday, down 0.6% at $120.22 in afternoon trade, after moving between $119.87 and $121.49. The muted move still mattered on the final trading day of the year, with oil prices on track for their steepest annual decline since 2020 and investors recalibrating expectations for 2026 cash flow across the sector. For integrated oil majors like Exxon, small changes in crude prices and refinery profitability can swing sentiment quickly, especially in holiday-thinned trading when liquidity is lighter. Brent crude, the global benchmark, was hovering
GE Vernova stock today: GEV edges lower in thin year-end trade as Wall Street dips

GE Vernova stock today: GEV edges lower in thin year-end trade as Wall Street dips

NEW YORK, December 31, 2025, 14:15 ET — Regular session. GE Vernova Inc. shares edged lower on Wednesday, sliding about 0.4% to $657.30 in afternoon trading as investors pared risk into the final session of 2025. The stock traded between $647.71 and $666.30. The move matters because GE Vernova has become a high-profile way to play rising spending on power generation and grid equipment, a theme tied to the buildout of electricity-hungry data centers. Into year-end, small shifts in positioning can move even large-cap stocks. With the New Year holiday set to interrupt trading and investors rebalancing portfolios, GE Vernova’s
AppLovin (NASDAQ: APP) stock dips today as year-end tech pullback pressures growth names

AppLovin (NASDAQ: APP) stock dips today as year-end tech pullback pressures growth names

NEW YORK, December 31, 2025, 14:13 ET — Regular session AppLovin Corp shares fell 1.3% to $685.00 in afternoon trading on Wednesday. The stock ranged between $682.73 and $698.23. The move tracked a modest dip in major U.S. indexes in the final trading session of 2025, with technology shares among the biggest drags as holiday-thinned liquidity amplified small swings. Reuters Treasury yields ticked higher after new data showed jobless claims fell to 199,000 in the week ended Dec. 27, undershooting economists’ expectations for a rise. Higher yields raise the discount rate investors use to value future profits, a headwind for
Applied Digital (APLD) climbs on fresh analyst calls as ChronoScale spin-off plan stays in focus

Applied Digital (APLD) climbs on fresh analyst calls as ChronoScale spin-off plan stays in focus

NEW YORK, December 31, 2025, 14:00 ET — Regular session Applied Digital Corporation shares rose about 4.6% to $25.20 in afternoon trading on Wednesday, after a burst of upbeat analyst coverage ahead of the company’s earnings next week. Northland Capital Markets analyst Mike Grondahl maintained an Outperform rating with a $40 price target, while Lake Street analyst Rob Brown reiterated a Buy rating and kept a $45 target, Benzinga reported. Northland also named Applied Digital its top pick for 2026, citing demand for power from hyperscalers — the largest cloud providers — and a potential move toward a REIT, or
Corcept Therapeutics (CORT) stock dives nearly 50% after FDA rejects relacorilant — what investors watch next

Corcept Therapeutics (CORT) stock dives nearly 50% after FDA rejects relacorilant — what investors watch next

NEW YORK, December 31, 2025, 13:58 ET — Regular session Shares of Corcept Therapeutics Incorporated (CORT.O) sank nearly 50% on Wednesday after the U.S. Food and Drug Administration issued a complete response letter for the company’s relacorilant application in hypertension secondary to hypercortisolism, also known as Cushing’s syndrome. The stock was down 49.7% at $35.31 in afternoon trading. Nasdaq The decision lands at a sensitive moment for investors who had been looking to relacorilant as the company’s next product story in Cushing’s beyond its marketed therapy. “FDA’s request for additional data may require additional trials, significantly dimming Corcept’s outlook in
JPMorgan stock edges up in thin year-end trade as Fed minutes and funding markets steer banks

JPMorgan stock edges up in thin year-end trade as Fed minutes and funding markets steer banks

NEW YORK, December 31, 2025, 13:56 ET — Regular session JPMorgan Chase & Co (JPM.N) shares were up 0.3% at $324.25 in afternoon trading on Wednesday, moving in a narrow range in the final U.S. equity session of 2025. The muted move matters because big U.S. banks are heading into January with two rate-sensitive crosscurrents: a Federal Reserve that has started cutting but remains divided on how much more, and a year-end squeeze in short-term funding markets. For JPMorgan, the direction of rates can quickly show up in results. Higher market yields can support net interest income — the gap
AST SpaceMobile (ASTS) stock slips today as insider buy filing, AT&T satellite update keep launch focus

AST SpaceMobile (ASTS) stock slips today as insider buy filing, AT&T satellite update keep launch focus

NEW YORK, December 31, 2025, 13:57 ET — Regular session AST SpaceMobile, Inc. (ASTS) shares were down 0.8% at $74.05 in early afternoon trading on Wednesday, after swinging between $72.53 and $75.73. The Nasdaq-tracking Invesco QQQ was off about 0.2%. The pullback matters because AST’s valuation has become tightly linked to a handful of near-term execution checkpoints: satellite launches, ground network buildout and carrier readiness. Those milestones can move the stock even when the broader market is quiet. The company is trying to deliver “direct-to-device” connectivity — linking satellites to standard smartphones without specialized equipment — and investors are watching
BitMine Immersion (BMNR) stock slips today as SEC filing flags $13.2B crypto stash and Jan. 15 vote

BitMine Immersion (BMNR) stock slips today as SEC filing flags $13.2B crypto stash and Jan. 15 vote

NEW YORK, December 31, 2025, 13:54 ET — Regular session Shares of BitMine Immersion Technologies, Inc. fell about 1.5% to $27.30 on Wednesday, giving back early gains as investors weighed the company’s latest proxy-related disclosures and choppy year-end crypto trading. SEC The stock has become a fast-moving proxy for ether prices, after BitMine pivoted toward building a large cryptocurrency “treasury” — a balance-sheet strategy where the company holds digital assets rather than treating them as a byproduct of operations. That linkage matters into the final two sessions of 2025, when liquidity can thin out and tax-driven repositioning tends to exaggerate
IREN stock slips in New York trade as bitcoin eases into year-end

IREN stock slips in New York trade as bitcoin eases into year-end

NEW YORK, December 31, 2025, 13:50 ET — Regular session IREN Limited shares fell about 1% on Wednesday to $37.92, paring earlier losses as the price of bitcoin drifted lower. The Nasdaq-listed company sits at the intersection of two volatile trades: bitcoin mining and data centers built for artificial intelligence workloads. That combination has made the stock sensitive to shifts in crypto prices and risk appetite. Reuters Moves late in the year can also be magnified by portfolio adjustments, as funds lock in gains or harvest losses before the calendar turns. “Some year-end rebalancing is going on,” Michael Dehal, senior
Eli Lilly stock today: LLY slips as China Mounjaro cuts and U.S. pricing reset draw focus

Eli Lilly stock today: LLY slips as China Mounjaro cuts and U.S. pricing reset draw focus

NEW YORK, December 31, 2025, 13:48 ET — Regular session Eli Lilly shares edged lower on Wednesday as investors weighed new signals that blockbuster diabetes and obesity drugs are heading into 2026 with lower price tags in some markets. The stock was down 0.1% at $1,078.95 by 1:48 p.m. ET, after trading between $1,076.86 and $1,083.25. The pricing debate matters for Lilly because its growth story is dominated by GLP-1 drugs, a class of diabetes and obesity treatments that mimic a gut hormone to curb appetite and lower blood sugar. Moves that broaden access can lift volumes, but price cuts
Sandisk stock today: SNDK dips as company sets Jan. 29 earnings date

Sandisk stock today: SNDK dips as company sets Jan. 29 earnings date

NEW YORK, December 31, 2025, 13:52 ET — Regular session Sandisk Corp shares were down 1.1% at $237.64 on Wednesday, after the flash-memory maker set Jan. 29 for its fiscal second-quarter results as year-end trading stayed thin. The stock has ranged from $235.54 to $241.69, while peers Western Digital, Micron Technology and Seagate Technology also traded lower and the broader market drifted modestly down. The timing matters because Sandisk has been one of 2025’s biggest winners, rising nearly 600% since returning to the market after being spun off from Western Digital earlier this year and joining the S&P 500 in

Stock Market Today

GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
GSK shares closed Friday up 0.83% at a 52-week high after the EU approved Nucala for certain uncontrolled COPD patients. Insider filings showed chairman Jonathan Symonds bought 2,500 shares while executive David Redfern sold 100,000. The FTSE 100 rose 0.6%. Broker ratings on GSK remained mixed.
Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

7 February 2026
Aye Finance raised Rs 454.5 crore from 19 anchor investors ahead of its Feb 9 IPO, pricing shares at the top of a Rs 122–129 range. The company’s profit fell 40% to Rs 64.3 crore in the six months to September as bad loans rose to 4.85%. The IPO values Aye at about Rs 3,200 crore, below its last private round. Major investors include Nippon Life India and Goldman Sachs funds.
Go toTop